XYD-A01

N/A

Report date: 2026/01/27 10:54:42
NME

Base Information

Drug NameXYD-A01
Drug Alias Nameintravenous nanocarrier chemotherapy formulation delivering SN-38XYD-A01XYDA01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursLiver NeoplasmsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKunshan Xinyunda Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKunshan Xinyunda Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLiver NeoplasmsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A